PDL BioPharma, Inc. Share Based Compensation of Revenue

Share Based Compensation of Revenue of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending June 29, 2020 was 4.43% (a -98.51% decrease compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue decreased by -10.87%
  • Annual Share Based Compensation of Revenue for 2019 was 13.0% (a 441.67% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2018 was 2.4% (a 144.9% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2017 was 0.98% (a -35.95% decrease from previous year)
  • Twelve month Share Based Compensation of Revenue ending June 29, 2020 was 42.29% (a -3.84% decrease compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue increased by 717.99% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
42.29% 43.98% 13.0% 5.17%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of PDL BioPharma, Inc.

Most recent Share Based Compensation of Revenueof PDLI including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of PDL BioPharma, Inc.

PDL BioPharma, Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 4.43% 296.4%
2019 -48.18% 4.97% 28.09% 16.65% 13.0%
2018 -0.12% 3.82% 2.71% 2.48% 2.4%
2017 0.18% 1.5% 0.67% 2.45% 0.98%
2016 1.64% 1.96% 3.86% 0.76% 1.53%
2015 0.39% 0.5% 0.16% 0.33% 0.35%
2014 0.41% 0.25% 0.26% 0.14% 0.26%
2013 0.27% 0.19% 0.15% 0.17% 0.19%
2012 0.28% 0.28% 0.18% 0.26% 0.25%
2011 0.18% 0.3% -0.04% 0.06% 0.11%
2010 0.18% 0.19% 0.14% 0.19%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.